Menu Appointment Contact Us Visit Us Patient Portal
the pain ends here
Call (210) 293-3136 and Like Our Page
Start Your Treatment
September 18, 2017| Stem Cell Orthopedic Institute of Texas Team | STEM CELL THERAPY
If you have any interest in stem cells, you may be familiar with the debate on embryonic stem cells. Stem cells have been researched since the mid-1900s. While adult stem cells have proven to be safe and effective, embryonic stem cells are banned for human use in the United States.
As such, at the Stem Cell Orthopedic Institute, we exclusively use adult stem cells. For a complete description of our process, please visit our procedure overview.
While we do not use embryonic stem cells in America, it is important to remember how we got to this point to inform what choices we make going forward. Heres the truth about embryonic stem cells:
Just like the name sounds, embryonic stem cells are derived from embryos. Most embryonic stem cells come from embryos that develop from eggs that were fertilized in vitro (in an in vitro fertilization clinic) and then donated for research purposes with the donors consent. These stem cells are not derived from the eggs that have been fertilized in a womans body.
Fertilization usually occurs in the oviduct. The few days after the embryo travels down the oviduct and into the uterus, a series of cleavage divisions will occur. The embryo is a ball of around 100 cells at this point (called a blastocyst). The outer layer of cells forms the placenta and is called the trophectoderm. The cells during this stage are undifferentiated, which means that they do not look or act like the specialized adult cells, and they are not yet committed to becoming any specific type of differentiated cell.
The first differentiation event occurs at around five days of development which is when an outer layer of cells separates from the inner cell mass (ICM). The ICM cells have the potential to generate any cell type, but once they have been implanted, they are quickly depleted as they differentiate into other cell types with limited developmental potential. However, the ICM cells can continue to multiply and endlessly replicate themselves, while maintaining the developmental potential to form any cell only if the ICM is removed from its normal embryonic environment and cultured under proper conditions.
Embryonic stem cells have a never-ending lifespan with an almost unlimited developmental potential. Embryonic stem cells are pluripotent, which means that can grow into any one of the three primary germ layers: ectoderm, endoderm, and mesoderm. These cells have the potential to form any type of cell in the body, from muscle to nerve to blood. Embryonic stem cells provide endless possibilities for researchers.
In 2001, President George W. Bush allowed federal funding for limited embryonic stem cell research. However, President Barack Obama revoked that statement in 2009 and released Executive Order 13505 to remove the restrictions on federal funding for stem cell research. This allowed the National Institutes of Health (NIH) to fully fund research with embryonic stem cells. The NIH issued guidelines to establish the policy. These guidelines were created to help ensure that all NIH-funded research on human stem cells is morally responsible and scientifically relevant.
Embryonic stem cells are used for many purposes, from basic research to transplantation therapies for various diseases like heart disease, Parkinsons disease, leukemia, and more. Since it is illegal to use human embryonic stem cells, researchers rely on mice and other animals for these cells. Stem cells have to potential to grow new cells to replace damaged organs or tissues, correct portions of organs that work improperly, research causes of genetic defects in cells, research how diseases occur or why certain cells develop into cancer cells and test new drugs for safety and effectiveness.
Research with embryonic stem cells (ESCs) is highly debated and many people have strong opinions about their stance on the issue. Many of the discussions lie around moral and ethical issues. The dilemma forces us to choose between two moral principles: the duty to prevent and alleviate suffering or the duty to respect the value of human life.
Lets take a look at both stances. In order to obtain embryonic stem cells, you must destroy the embryo also meaning that you are destroying a potential human life. On the other hand, embryonic stem cell research could help us find new medical treatments that could help alleviate or end those suffering from many disorders and diseases. The biggest question: which moral principle should have the upper hand? The answer ultimately depends on how you view the human embryo.
Embryonic stem cells also have a high oncogenic potential meaning it is potentially cancerous. Since these cells have the possibility to transform into practically any cell, there is a possibility they can form tumors in patients.
At the Stem Cell Orthopedic Institute of Texas, we never use embryonic stem cells only adult stem cells. Our patients health and safety is our priority. Rest assured, our doctors will give you the personalized attention you deserve. To learn more about our stem cell treatments or to schedule an appointment, call us at 210-293-3136.
Tags: embryonic stem cell therapy san antonio
Share this: Facebook Google+ Pinterest
Huebner Center South Texas Spinal Clinic 9150 Huebner Rd, ste. 290 San Antonio TX, 78240
Huebner Center South Texas Spinal Clinic 9150 Huebner Rd, ste. 290 San Antonio TX, 78240
Phone: Call 210-614-6432
See the original post:
Truth About Embryonic Stem Cells | Stem Cell Orthopedic ...
- Stem Cell Therapy Market by Treatment,Application,End Users and Geography Forecast To... - Azizsalon News - May 21st, 2020
- Georgetown student takes Islamic bioethics research at QF to Washington and wins - Gulf Times - May 21st, 2020
- Dose-dependent functions of SWI/SNF BAF in permitting and inhibiting cell proliferation in vivo - Science Advances - May 21st, 2020
- Human Embryonic Stem Cells (HESC) Market to witness an impressive growth during - News by aeresearch - May 20th, 2020
- Qatar- Georgetown student takes Islamic bioethics research at QF to Washington and wins - MENAFN.COM - May 15th, 2020
- Millions of Human Cells Have Been Grown Inside Mice Embryos - Newsweek - May 14th, 2020
- AgeX Therapeutics Reports First Quarter 2020 Financial Results and Provides Business Update - Business Wire - May 14th, 2020
- Human Embryonic Stem Cells (HESC) Market Growth by Top Companies, Trends by Types and Application, Forecast to 2026 - Cole of Duty - May 14th, 2020
- The Cell Therapy Industry to 2028: Global Market & Technology Analysis, Company Profiles of 309 Players (170 Involved in Stem Cells) -... - May 14th, 2020
- 2025 Projections: Cell Freezing Media for Cell Therapy Market Report by Type, Application and Regional Outlook - AlgosOnline - May 14th, 2020
- Tolero Pharmaceuticals Announces Expansion of the Zella 102 Study in Patients with Intermediate and High-Risk Myelodysplastic Syndromes (MDS) - The... - May 14th, 2020
- Strides in Medical Tourism Market Key Driver of Low-cost Patient Care in Globalized Healthcare Systems, Notes TMR - Stockhouse - May 14th, 2020
- Uses and Abuses of Scientific Consensus - National Review - May 13th, 2020
- Lineage Cell Therapeutics Reports New Data With OpRegen for the Treatment of Dry AMD With Geographic Atrophy - Business Wire - May 13th, 2020
- COVID-19 Impact on STEM CELL THERAPY MARKET 2020 TO 2027-EXPANDING WORLDWIDE WITH TOP PLAYERS FUTURE BUSINESS SCOPE AND INVESTMENT ANALYSIS REPORT -... - May 13th, 2020
- Human Embryonic Stem Cells (HESC) Market 2020 | Growth Drivers, Challenges, Trends, Market Dynamics and Forecast to 2026 - Cole of Duty - May 10th, 2020
- Louis Bacon Is Having The Time Of His Life - Dealbreaker - May 10th, 2020
- Lineage Cell Therapeutics Reports New Data With OpRegen for the Treatment of Dry AMD With Geographic Atrophy - Yahoo Finance - May 10th, 2020
- Human Embryonic Stem Cells, Germ Cells, and Cell-Derived ... - May 7th, 2020
- Inside the twisted world of 'rapist' designer Peter Nygard: book - The Loppy - May 4th, 2020
- Lack of investment is the biggest challenge in stem cell research - Express Healthcare - May 2nd, 2020
- AgeX Therapeutics: Revolutionary Potential But Extremely Early - Seeking Alpha - April 30th, 2020
- Human Embryonic Stem Cells (HESC) Market Overview, Top Companies, Region, Application and Global Forecast by 2026 - Latest Herald - April 27th, 2020
- Role of MyHC-embryonic protein in muscle development and disease - Tech Explorist - April 27th, 2020
- The Republicans who were once so pro-life they fought over one woman on life support now want to sacrifice grandma for the economy - The Independent - April 26th, 2020
- Sustainably Yours: The importance of understanding and trusting in Science - The Phuket News - April 26th, 2020
- Mogrify and Sangamo announce collaboration and exclusive license agreement for Mogrify's iPSC- and ESC-derived regulatory T cells - SelectScience - April 24th, 2020
- Stem Cell Therapy Market Research Outlook, Recent Trends and Growth Forecast 2020-2025 - Cole of Duty - April 24th, 2020
- Mogrify and Sangamo in license agreement for 'off-the-shelf' CAR-Treg - BioPharma-Reporter.com - April 23rd, 2020
- Lozier praises promising, and ethical, blindness study - OneNewsNow - April 23rd, 2020
- A potent CBP/p300-Snail interaction inhibitor suppresses tumor growth and metastasis in wild-type p53-expressing cancer - Science Advances - April 23rd, 2020
- PHF20L1 as a H3K27me2 reader coordinates with transcriptional repressors to promote breast tumorigenesis - Science Advances - April 21st, 2020
- Cyborg computer chips will get their brain from human neurons - SYFY WIRE - April 11th, 2020
- Stem Cells Market Expected to Boost the Global Industry Growth in the Near Future - Germany English News - April 11th, 2020
- Germline mutation of MDM4, a major p53 regulator, in a familial syndrome of defective telomere maintenance - Science Advances - April 11th, 2020
- Turning Back the Clock on Aging Cells - The New York Times - March 31st, 2020
- A New Way to Study HIV's Impact on the Brain - Global Health News Wire - March 31st, 2020
- Human Embryonic Stem Cell Market Analysis and Forecasts to 2027 By Recent Trends, Developments In Manufacturing Technology And Regional Growth... - March 31st, 2020
- Laboratory model looking at how a HIV infection impacts the brain - Health Europa - March 31st, 2020
- Cell Banking Outsourcing Market With Economic Growth And Five Forces Analysis By 2021 - Lake Shore Gazette - March 30th, 2020
- Global Human Embryonic Stem Cells Market Provides an In-Depth Insight of Sales Analysis, Growth Forecast and Upcoming Trends Opportunities by Types... - March 26th, 2020
- PD-1 Blocker Safe in Childhood Cancers. But Does It Work? - MedPage Today - March 19th, 2020
- YAP1 is a potent driver of the onset and progression of oral squamous cell carcinoma - Science Advances - March 19th, 2020
- Can hybrid embryos save the white rhinos from extinction? - Science 101 - March 17th, 2020
- Autologous Stem Cell Based Therapies Market 2020: Potential Growth, Challenges, Attractive Valuation | Key Players: Anterogen, Holostem Advanced... - March 17th, 2020
- Worldwide Cell Therapy Market Projections to 2028 - The Largest Expansion Will Be in Diseases of the Central Nervous System, Cancer and Cardiovascular... - March 15th, 2020
- 22.5% Growth Rate for Synthetic Stem Cells Market by 2028 | Overview, Top Technologies, Key Insights and Company Profiles - News Times - March 15th, 2020
- Single-Cell Analysis of Ovarian Cortex Fails to Find Stem Cells - The Scientist - March 7th, 2020
- Organoids, iPSCs, and advanced cell models: Advancing discovery from basic research to drug discovery - Science Magazine - March 2nd, 2020
- Stem Cell Therapy Market Opportunity Analysis and Industry Forecast up to 2017 2025 - Jewish Life News - March 2nd, 2020
- The very interesting life of the Hydractinia - Jill Lopez - February 28th, 2020
- Intrinsic disorder controls two functionally distinct dimers of the master transcription factor PU.1 - Science Advances - February 22nd, 2020
- Stem Cell Therapy Market: Business Opportunities, Current Trends and Industry Analysis by 2018 2028 - Instant Tech News - February 21st, 2020
- Anatomy of a grant: Ashley Kramer's yearlong journey to finding her doctoral thesis - The South End - February 21st, 2020
- The Challenge of Bioethics to Decision-Making in the UK - Westminster Abbey - February 21st, 2020
- The 411 on Stem Cells: What They Are and Why It's Important to Be Educated - Legal Examiner - February 17th, 2020
- Will Cultured Meat Soon Be A Common Sight In Supermarkets Across The Globe? - Forbes - February 17th, 2020
- Genetic Secrets of How a Strange Marine Animal Produces Unlimited Eggs and Sperm Over Its Lifetime - SciTechDaily - February 15th, 2020
- Stem Cells Market Report by Manufacturers, Regions, Type and Application Forecast 2020-2025, Trends, Proportions, Share and SWOT. - Chronicle 99 - February 15th, 2020
- Embryonic Stem Cells - February 11th, 2020
- 3. Embryonic Stem Cells | Stem Cells and the Future of ... - February 5th, 2020
- Embryonic Stem Cell Fact Sheet - February 5th, 2020
- Embryonic Stem Cell Research Pros and Cons - Biology Wise - February 5th, 2020
- Early onset Parkinsons might begin in the womb: Prevention a possibility - The New Daily - February 1st, 2020
- How does the embryo make all its parts at just the right moments? - Knowable Magazine - January 31st, 2020
- Biobanking Market to Witness an Outstanding Growth During 2019-2030 :Thermo Fisher Scientific Inc., PHC Holdings Corporation, QIAGEN NV - Media... - January 31st, 2020
- What are Progenitor Cells? Exploring Neural, Myeloid and Hematopoietic Progenitor Cells - Technology Networks - January 29th, 2020
- Lab-Grown Heart Muscles Have Been Transplanted Into a Human For The First Time - ScienceAlert - January 29th, 2020
- Antibodies recognizing the C terminus of PP2A catalytic subunit are unsuitable for evaluating PP2A activity and holoenzyme composition - Science - January 29th, 2020
- Comprehensive Research on Human Embryonic Stem Cells (HESC) Market Report 2026 | Astellas Pharma Inc/ Ocata Therapeutics ,STEMCELL Technologies... - January 26th, 2020
- Stem Cell Therapy Market Anticipated to Grow at a Significant Pace by 2020 - The Trusted Chronicle - January 26th, 2020
- What I Learned About Marriage as a Survivor of Abuse - SWAAY - January 26th, 2020
- Stem Cell Therapy Market Current Trends and Future Growth Dagoretti News - Dagoretti News - January 22nd, 2020
- Memphis Meats raises $161m to build its cell-based meat platform: 'We have a pretty clear path to bringing prices down to cost parity' -... - January 22nd, 2020
- Stem Cell Assay Market Predicted to Accelerate the Growth by 2017-2025 Dagoretti News - Dagoretti News - January 17th, 2020
- Team builds the 1st living robots - EarthSky - January 17th, 2020
- Team Builds the First Living Robots - Newswise - January 17th, 2020
- The 'xenobot' is the worlds newest robot and it's made from living animal cells - The Loop - January 17th, 2020
- Scientists Have Built The First-Ever Robots Constructed Entirely Out of Living Cells - ScienceAlert - January 14th, 2020
- Scientists Assemble Frog Stem Cells Into First 'Living Machines' - Smithsonian.com - January 13th, 2020